The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Hereditary Hemochromatosis — A New Look at an Old Disease
Abstract
For many years, hereditary hemochromatosis was regarded as a clinically and genetically unique entity marked by a classic presentation consisting of diabetes, bronze skin pigmentation, and cirrhosis. In 1996, identification of “the hemochromatosis gene,” HFE, was reported; since then, several other iron-metabolism genes have also been identified. This article reviews the current understanding and management of hereditary iron-overload disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The HFE mutation leads to an impaired formation of hepcidin and thus to an iron deficiency phenotype of MΦs, whereas excessively absorbed iron is stored in parenchymal organs such as the liver, heart, or pancreas.”
From Macrophage defense mechanisms against intracellular bacteria (2015) · cites this paper as [201]
In the citing paper
“Conversely, individuals with insufficient hepcidin production, suffer from iron-overload in the blood, and hepatitis (Pietrangelo, 2004).”
From The Role of Iron Regulation in Immunometabolism and Immune-Related Disease (2019) · cites this paper as Pietrangelo, 2004
In the citing paper
“HFE mutations, especially the homozygous C282Y substitution, result in type I (AKA classical) hereditary hemochromatosis (HH) (Camaschella et al., 2002; Pietrangelo, 2004; Weiss, 2010)”
From Genetic and Dietary Iron Overload Differentially Affect the Course of Salmonella Typhimurium Infection (2017) · cites this paper as Pietrangelo, 2004
In the citing paper
“HH is characterized by reduced serum levels of the antimicrobial peptide Hamp (hepcidin) and increased duodenal absorption of iron via divalent metal transporter 1 (Dmt1) and ferroportin 1 (Fpn1) despite progressive iron overload in parenchymal organs including the liver, pancreas, and heart (Zoller et al., 1999, 2001; Bridle et al., 2003; Pietrangelo, 2004; Bardou-Jacquet et al., 2013).”
From Genetic and Dietary Iron Overload Differentially Affect the Course of Salmonella Typhimurium Infection (2017) · cites this paper as Pietrangelo, 2004
In the citing paper
“Hfe deficiency results in reduced Hamp production and increased serum iron levels (Pietrangelo, 2004).”
From Genetic and Dietary Iron Overload Differentially Affect the Course of Salmonella Typhimurium Infection (2017) · cites this paper as Pietrangelo, 2004
In the citing paper
“The proximal region of the human ferritin H gene was activated by NF-Y and p300 during hemin-induced FLC differentiation, and this proximal region was also responsible for cAMP (80, 194, 248).”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [248]
Citations
Cites
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., Dormishian, F., Domingo, R., Ellis, M. C., Fullan, A., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-399 · Cited by 3,664
Hepcidin, a urinary antimicrobial peptide synthesized in the liver
Park, C. H., Valore, E. V., Waring, A. J., & Ganz, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008922200 · Cited by 2,168
Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion
den Dunnen, J. T., & Antonarakis, S. E. (2000) · Human Mutation · doi:10.1002/(sici)1098-1004(200001)15:1 · Cited by 1,757
Pigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., Brissot, P., & Loréal, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008923200 · Cited by 1,697
Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation
Ganz, T. (2003) · Blood · doi:10.1182/blood-2003-03-0672 · Cited by 1,544
Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein
Nemeth, E., Valore, E. V., Territo, M., Schiller, G., Lichtenstein, A., & Ganz, T. (2003) · Blood · doi:10.1182/blood-2002-10-3235 · Cited by 1,417
LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity
Krause, A., Neitz, S., Mägert, H.-J., Schulz, A., Forssmann, W.-G., Schulz-Knappe, P., & Adermann, K. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01920-7 · Cited by 1,324
Survival and Causes of Death in Cirrhotic and in Noncirrhotic Patients with Primary Hemochromatosis
Niederau, C., Fischer, R., Sonnenberg, A., Stremmel, W., Trampisch, H. J., & Strohmeyer, G. W. (1985) · New England Journal of Medicine · doi:10.1056/nejm198511143132004 · Cited by 1,063
Mutations in HFE2 cause iron overload in chromosome 1q–linked juvenile hemochromatosis
Papanikolaou, G., Samuels, M. E., Ludwig, E. H., MacDonald, M. L. E., Franchini, P. L., Dubé, M.-P., Andres, L., MacFarlane, J., Sakellaropoulos, N., Politou, M., et al. (2004) · Nature Genetics · doi:10.1038/ng1274 · Cited by 974
Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis
Roetto, A., Papanikolaou, G., Politou, M., Alberti, F., Girelli, D., Christakis, J., Loukopoulos, D., & Camaschella, C. (2003) · Nature Genetics · doi:10.1038/ng1053 · Cited by 860
Flagged first, then by citations
Research works printed but not linked: 10
- Troisier M, 1871, Bull Soc Anat Paris, 44, 231
- von Recklinghausen FD, 1889, Tageblatt Versammlung Dtsche Naturforscher Arzte Heidelberg, 62, 324
- Sheldon JH. Haemochromatosis. London: Oxford University Press, 1935.
- Simon M, 1975, Nouv Presse Med, 4, 1432
- Simon M, 1987, Am J Hum Genet, 41, 89
- Cook JD, 1973, Am J Pathol, 72, 337
- Smith PM, 1969, Clin Sci, 37, 519
- McLaren GD, 1991, J Lab Clin Med, 117, 390
- Powell LW, 2002, Semin Gastrointest Dis, 13, 80
- Hayashi A, 1993, Am J Hum Genet, 53, 201
Cited by
Sorted by citations
Items 101–200 of 991
Biological Variability of Transferrin Saturation and Unsaturated Iron-Binding Capacity
Adams, P. C., Reboussin, D. M., Press, R. D., Barton, J. C., Acton, R. T., Moses, G. C., Leiendecker‐Foster, C., McLaren, G. D., Dawkins, F. W., Gordeuk, V. R., et al. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.02.027 · Cited by 122
Iron Regulation of Pancreatic Beta-Cell Functions and Oxidative Stress
Backe, M. B., Moen, I. W., Ellervik, C., Hansen, J. B., & Mandrup-Poulsen, T. R. (2016) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071715-050939 · Cited by 119
Das, S. K., Wang, W., Zhabyeyev, P., Basu, R., McLean, B. A., Dong, F., Parajuli, N., DesAulniers, J., Patel, V. B., Hajjar, R. J., et al. (2015) · Scientific Reports · doi:10.1038/srep18132 · Cited by 115
Hepcidin--the iron regulatory hormone.
Rossi, E. (2005) · Europe PMC (PubMed Central) · Cited by 112
A diagnostic approach to hyperferritinemia with a non-elevated transferrin saturation
Adams, P. C., & Barton, J. C. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.02.010 · Cited by 113
Dysregulation of iron and copper homeostasis in nonalcoholic fatty liver
Aigner, E. S. (2014) · World Journal of Hepatology · doi:10.4254/wjh.v7.i2.177 · Cited by 116
Roy, C. N. (2010) · Hematology · doi:10.1182/asheducation-2010.1.276 · Cited by 114
Wilson, K., Girdler, N. M., & Welbury, R. R. (2003) · British Journal of Anaesthesia · doi:10.1093/bja/aeg278 · Cited by 110
Fetal and infantile hemochromatosis†
Whitington, P. F. (2006) · Hepatology · doi:10.1002/hep.21129 · Cited by 108
Becker, F., van El, C. G., Ibarreta, D., Zika, E., Hogarth, S., Borry, P., Cambon‐Thomsen, A., Cassiman, J. J., Evers‐Kiebooms, G., Hodgson, S. V., et al. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2010.249 · Cited by 110
Reardon, T. F., & Allen, D. G. (2009) · Experimental Physiology · doi:10.1113/expphysiol.2008.046045 · Cited by 110
Hepatic iron overload and hepatocellular carcinoma
Kew, M. C. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.11.001 · Cited by 109
The penetrance of hereditary hemochromatosis
Waalen, J., Nordestgaard, B. G., & Beutler, E. (2005) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2004.08.023 · Cited by 109
Lessons from studying monogenic disease for common disease
Peltonen, L., Perola, M., Naukkarinen, J., & Palotie, A. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl060 · Cited by 105
The flatiron mutation in mouse ferroportin acts as a dominant negative to cause ferroportin disease.
Zohn, I. E., De Domenico, I., Pollock, A., Ward, D. M., Goodman, J. F., Liang, X., Sanchez, A. J., Niswander, L., & Kaplan, J. (2007) · Blood · doi:10.1182/blood-2007-01-066068 · Cited by 104
Current Approaches to the Management of Hemochromatosis
Brissot, P., & BELS, F. D. (2006) · Hematology · doi:10.1182/asheducation-2006.1.36 · Cited by 107
Corradini, E., Rozier, M., Meynard, D., Odhiambo, A., Lin, H. Y.-F., Feng, Q., Migas, M. C., Britton, R. S., Babitt, J. L., & Fleming, R. E. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.077 · Cited by 102
Genetic Diagnosis and Testing in Clinical Practice
McPherson, E. W. (2006) · Clinical Medicine & Research · doi:10.3121/cmr.4.2.123 · Cited by 106
ER Stress-Inducible Factor CHOP Affects the Expression of Hepcidin by Modulating C/EBPalpha Activity
Oliveira, S. J., Pinto, J. P., Picarote, G., Costa, V. M., Carvalho, F. D., Rangel, M., de Sousa, M. A. B., & de Almeida, S. F. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006618 · Cited by 101
Pietrangelo, A. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.05.013 · Cited by 105
Self-citationPietrangelo, A., Caleffi, A., & Corradini, E. (2011) · Seminars in Liver Disease · doi:10.1055/s-0031-1286061 · Cited by 99
Self-citationFamily history: the three-generation pedigree.
Wattendorf, D. J., & Hadley, D. W. (2005) · PubMed · Cited by 97
Olynyk, J. K., Pierre, T. G. S., Britton, R. S., Brunt, E. M., & Bacon, B. R. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41287.x · Cited by 98
Adhoute, X., Foucher, J., Laharie, D., Terrebonne, É., Vergniol, J., Castéra, L., Lovato, B., Chanteloup, E., Merrouche, W., Couzigou, P., et al. (2008) · Gastroentérologie Clinique et Biologique · doi:10.1016/j.gcb.2007.12.021 · Cited by 100
The Ins and Outs of Iron Homeostasis
Donovan, A., Roy, C. N., & Andrews, N. C. (2006) · Physiology · doi:10.1152/physiol.00052.2005 · Cited by 101
Hereditary hemochromatosis in the post- HFE era
Olynyk, J. K., Trinder, D., Ramm, G. A., Britton, R. S., & Bacon, B. R. (2008) · Hepatology · doi:10.1002/hep.22507 · Cited by 97
α1‐Antitrypsin mutations in NAFLD
Valenti, L. V. C., Dongiovanni, P., Piperno, A., Fracanzani, A. L., Maggioni, M., Rametta, R., Loria, P., Casiraghi, M. A., Suigo, E., Ceriani, R., et al. (2006) · Hepatology · doi:10.1002/hep.21329 · Cited by 93
Ferroportin1 is required for normal iron cycling in zebrafish
Fraenkel, P. G., Traver, D. J., Donovan, A., Zahrieh, D., & Zon, L. I. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23780 · Cited by 94
Daher, R., Kannengiesser, C., Houamel, D., Lefèbvre, T., Bardou‐Jacquet, E., Ducrot, N., de Kerguenec, C., Jouanolle, A., Robréau, A.-M., Oudin, C., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.10.049 · Cited by 98
Gender differences in liver disease and the drug-dose gender gap
Buzzetti, E., Parikh, P. M., Gerussi, A., & Tsochatzis, E. A. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.03.014 · Cited by 94
Burnweit, C. A., Zerpa, J., Nahmad, M., Lankau, C. A., Weinberger, M., Malvezzi, L., Smith, L., Shapiro, T., & Thayer, K. (2004) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2003.11.037 · Cited by 92
‘Ride on the ferrous wheel’ – The cycle of iron in macrophages in health and disease
Nairz, M., Schroll, A., Demetz, E., Tancevski, I., Theurl, I., & Weiss, G. (2015) · Immunobiology · doi:10.1016/j.imbio.2014.09.010 · Cited by 89
Fargion, S. R., Valenti, L. V. C., & Fracanzani, A. L. (2010) · Digestive and Liver Disease · doi:10.1016/j.dld.2010.07.006 · Cited by 89
Use of community genetic screening to prevent HFE-associated hereditary haemochromatosis
Delatycki, M., Allen, K. J., Nisselle, A. E., Collins, V., Metcalfe, S. A., du Sart, D., Halliday, J. L., Aitken, M., Macciocca, I., Hill, V., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)63012-7 · Cited by 88
Finkenstedt, A., Wolf, E., Höfner, E., Gasser, B. I., Boesch, S., Bakry, R. S., Creus, M., Kremser, C., Schocke, M., Theurl, M., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.04.039 · Cited by 90
Mechanisms of Haem and Non-Haem Iron Absorption: Lessons from Inherited Disorders of Iron Metabolism
Anderson, G. J., Frazer, D. M., McKie, A. T., Vulpe, C. D., & Smith, A. (2005) · BioMetals · doi:10.1007/s10534-005-3708-8 · Cited by 90
The molecular genetics of haemochromatosis
Gac, G. L., & Férec, C. (2005) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201490 · Cited by 89
Iron overload due to mutations in ferroportin.
Domenico, I. D., Ward, D. M., Musci, G., & Kaplan, J. (2006) · PubMed · Cited by 84
Neuroferritinopathy: a neurodegenerative disorder associated with L-ferritin mutation
Levi, S., Cozzi, A., & Arosio, P. (2005) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2004.08.021 · Cited by 84
McLaren, C. E., Emond, M. J., Subramaniam, V. N., Phatak, P. D., Barton, J. C., Adams, P. C., Goh, J. B., McDonald, C. J., Powell, L. W., Gurrin, L. C., et al. (2015) · Hepatology · doi:10.1002/hep.27711 · Cited by 84
Genetic mechanisms and modifying factors in hereditary hemochromatosis
Weiss, G. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2009.201 · Cited by 82
Weinberg, E. D. (2010) · Metallomics · doi:10.1039/c0mt00023j · Cited by 84
Understanding How Minerals Contribute to Optimal Immune Function
Ştefanache, A., Lungu, I. I., Butnariu, I.-A., Călin, G., Guțu, C., Marcu, C., Grierosu, C., Goroftei, E. R. B., Duceac, L.-D., Dabija, M. G., et al. (2023) · Journal of Immunology Research · doi:10.1155/2023/3355733 · Cited by 99
Nihoyannopoulos, P., & Dawson, D. M. (2009) · European Journal of Echocardiography · doi:10.1093/ejechocard/jep156 · Cited by 80
Hereditary iron overload: Update on pathophysiology, diagnosis, and treatment
Franchini, M. (2006) · American Journal of Hematology · doi:10.1002/ajh.20493 · Cited by 81
Iron Load Toxicity in Medicine: From Molecular and Cellular Aspects to Clinical Implications
Kontoghiorghes, G. J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612928 · Cited by 91
Brudevold, R., Hole, T., & Hammerstrøm, J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003547 · Cited by 80
New insights into the regulation of iron homeostasis
Deicher, R., & Hörl, W. H. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01633.x · Cited by 80
Smith, C. P., & Thévenod, F. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.10.010 · Cited by 80
Musculoskeletal Complications of Hereditary Hemochromatosis: A Case-Control Study
Richette, P., Ottaviani, S., Vicaut, É., & Bardin, T. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.100234 · Cited by 78
Dopamine promotes cellular iron accumulation and oxidative stress responses in macrophages
Dichtl, S., Haschka, D., Nairz, M., Seifert, M., Volani, C., Lutz, O., & Weiss, G. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.12.001 · Cited by 76
Allen, K. J., Bertalli, N. A., Osborne, N. J., Constantine, C. C., Delatycki, M. B., Nisselle, A. E., Nicoll, A., Gertig, D. M., McLaren, C. E., Giles, G. G., et al. (2010) · Hepatology · doi:10.1002/hep.23786 · Cited by 82
Schmitt, B. P., Golub, R. M., & Green, R. R. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-7-200510040-00011 · Cited by 76
Preemptive Analgesia at the Crossroad
Kissin, I. (2005) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000144429.39988.9b · Cited by 76
A Practical Approach to Early-Onset Parkinsonism
Riboldi, G. M., Frattini, E., Monfrini, E., Frucht, S. J., & Fonzo, A. D. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-212815 · Cited by 82
Iron: Effect of Overload and Deficiency
Hider, R. C., & Kong, X. (2013) · Metal ions in life sciences · doi:10.1007/978-94-007-7500-8_8 · Cited by 78
Sutedja, N. A., Sinke, R. J., van Vught, P. W. J., van der Linden, M. W., Wokke, J. H. J., van Duijn, C. M., Njajou, O. T., van der Schouw, Y. T., Veldink, J. H., & van den Berg, L. H. (2007) · Archives of Neurology · doi:10.1001/archneur.64.1.63 · Cited by 74
Siah, C. W., Trinder, D., & Olynyk, J. K. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2005.02.022 · Cited by 75
Iron overload in the liver diagnostic and quantification
Alústiza, J. M., Castiella, A., de Juan, M. D., Emparanza, J. I., Artetxe, J., & Uranga, M. U. (2006) · European Journal of Radiology · doi:10.1016/j.ejrad.2006.11.012 · Cited by 74
Clinical Manifestations of Hemochromatosis in HFE C282Y Homozygotes Identified by Screening
McLaren, G. D., McLaren, C. E., Adams, P. C., Barton, J. C., Reboussin, D. M., Gordeuk, V. R., Acton, R. T., Harris, E. L., Speechley, M. R., Sholinsky, P. D., et al. (2008) · Canadian Journal of Gastroenterology · doi:10.1155/2008/907356 · Cited by 72
Theurl, I., Fritsche, G., Ludwiczek, S., Garimorth, K., Bellmann-Weiler, R., & Weiss, G. (2005) · BioMetals · doi:10.1007/s10534-005-3710-1 · Cited by 72
Mechanisms of divalent metal toxicity in affective disorders
Menon, A. V., Chang, J., & Kim, J. (2015) · Toxicology · doi:10.1016/j.tox.2015.11.001 · Cited by 77
Ferroptosis and its role in cardiomyopathy
Li, D., Pi, W., Sun, Z., Liu, X., & Jiang, J. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113279 · Cited by 72
Aguilar‐Martinez, P., Schved, J., & Brissot, P. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.40998.x · Cited by 73
Spectrum of Restrictive and Infiltrative Cardiomyopathies
Pereira, N. L., Grogan, M. A., & Dec, G. W. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.01.017 · Cited by 71
Intermediate phenotypes in schizophrenia: a selective review
Preston, G. A., & Weinberger, D. R. (2005) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2005.7.2/gpreston · Cited by 70
Ethnic Differences in Iron Status
Kang, W., Barad, A., Clark, A. G., Wang, Y., Xu, L., Gu, Z., & O'Brien, K. O. (2021) · Advances in Nutrition · doi:10.1093/advances/nmab035 · Cited by 76
Iron inhibits replication of infectious hepatitis C virus in permissive Huh7.5.1 cells
Fillebeen, C., & Pantopoulos, K. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.04.044 · Cited by 71
Lubitz, S. A., Goldbarg, S. H., & Mehta, D. (2008) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2007.10.003 · Cited by 71
Kupffer cells modulate iron homeostasis in mice via regulation of hepcidin expression
Theurl, M., Theurl, I., Hochegger, K., Obrist, P., Subramaniam, N., van Rooijen, N., Schuemann, K., & Weiss, G. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0346-y · Cited by 69
Krijt, J., Vokurka, M., Chang, K., & Nečas, E. (2004) · Blood · doi:10.1182/blood-2004-06-2422 · Cited by 69
Elevated Transferrin Saturation and Risk of Diabetes
Ellervik, C., Mandrup-Poulsen, T. R., Andersen, H. U., Tybjærg‐Hansen, A., Frandsen, M., Birgens, H., & Nordestgaard, B. G. (2011) · Diabetes Care · doi:10.2337/dc11-0416 · Cited by 68
Pietrangelo, A., & Trautwein, C. (2004) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0019 · Cited by 69
Self-citationKupffer cells and macrophages are not required for hepatic hepcidin activation during iron overload†
Montosi, G., Corradini, E., Garuti, C., Barelli, S., Recalcati, S., Cairo, G., Valli, L., Pignatti, E., Vecchi, C., Ferrara, F., et al. (2005) · Hepatology · doi:10.1002/hep.20620 · Cited by 67
Self-citationPharmacogenetics of Adverse Drug Reactions
Osanlou, O., Pirmohamed, M., & Daly, A. K. (2018) · Advances in pharmacology · doi:10.1016/bs.apha.2018.03.002 · Cited by 69
Ryan, J. D., Ryan, E. M., Fabre, A., Lawless, M. W., & Crowe, J. (2010) · Hepatology · doi:10.1002/hep.23814 · Cited by 68
Pathophysiology of Hereditary Hemochromatosis
Fleming, R. E., Britton, R. S., Waheed, A., Sly, W. S., & Bacon, B. R. (2005) · Seminars in Liver Disease · doi:10.1055/s-2005-923313 · Cited by 68
A comparison of oral midazolam and nitrous oxide sedation for dental extractions in children
Wilson, K. E., Girdler, N. M., & Welbury, R. R. (2006) · Anaesthesia · doi:10.1111/j.1365-2044.2006.04835.x · Cited by 67
Distinct requirements for Hfe in basal and induced hepcidin levels in iron overload and inflammation
Constante, M., 蒋文雷, Wang, D., Raymond, V., Bilodeau, M., & Santos, M. M. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00092.2006 · Cited by 66
Synovial immunopathology in haemochromatosis arthropathy
Heiland, G. R., Aigner, E., Dallos, T., Sahinbegovic, E., Krenn, V., Thaler, C., Weiss, G., Distler, J. H., Datz, C., Schett, G., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.120204 · Cited by 64
Transferrin-a modulates hepcidin expression in zebrafish embryos
Fraenkel, P. G., Gibert, Y., Holzheimer, J., Lattanzi, V. J., Burnett, S. F., Dooley, K. A., Wingert, R. A., & Zon, L. I. (2008) · Blood · doi:10.1182/blood-2008-06-165340 · Cited by 66
Molecular mechanism of intestinal iron absorption
Han, O. (2011) · Metallomics · doi:10.1039/c0mt00043d · Cited by 70
Chan, A. T., Ma, J., Tranah, G. J., Giovannucci, E. L., Rifai, N., Hunter, D. J., & Fuchs, C. S. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji165 · Cited by 64
Beutler, E. (2004) · Science · doi:10.1126/science.1107224 · Cited by 63
Hepcidin: an important new regulator of iron homeostasis
Hugman, A. (2006) · Clinical & Laboratory Haematology · doi:10.1111/j.1365-2257.2006.00768.x · Cited by 62
Primary iron overload with inappropriate hepcidin expression in V162del ferroportin disease†
Zoller, H., McFarlane, I., Theurl, I., Stadlmann, S., Nemeth, E., Oxley, D., Ganz, T., Halsall, D. J., Cox, T. M., & Vogel, W. (2005) · Hepatology · doi:10.1002/hep.20775 · Cited by 62
Lou, D., Lesbordes, J., Nicolas, G., Viatte, L., Bennoun, M., Van Rooijen, N., Kahn, A., Renia, L., & Vaulont, S. (2005) · Hepatology · doi:10.1002/hep.20663 · Cited by 62
McCune, C. A. (2005) · Gut · doi:10.1136/gut.2005.070342 · Cited by 63
Genetic Testing: Practical, Ethical, and Counseling Considerations
Ensenauer, R. E., Michels, V. V., & Reinke, S. S. (2005) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)62960-1 · Cited by 62
Identification of new mutations of hepcidin and hemojuvelin in patients with HFE C282Y allele
Biasiotto, G., Roetto, A., Daraio, F., Polotti, A., Gerardi, G. M., Girelli, D., Cremonesi, L., Arosio, P., & Camaschella, C. (2004) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2004.08.002 · Cited by 62
Li, X., Chu, Y., Ma, R., Dou, M., Li, S., Song, Y., Lv, Y., & Zhu, L. D. (2022) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2022.577995 · Cited by 62
Optimizing Diagnosis From the Medical Liver Biopsy
Czaja, A. J., & Carpenter, H. A. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.05.031 · Cited by 59
Ellervik, C., Marott, J. L., Tybjærg‐Hansen, A., Schnohr, P., & Nordestgaard, B. G. (2014) · Clinical Chemistry · doi:10.1373/clinchem.2014.229013 · Cited by 65
Serum Ferritin and Transferrin Saturation in Asians and Pacific Islanders
Harris, E. L. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.7.722 · Cited by 61
Relationship between Hepatitis C Virus Infection and Iron Overload
Zou, D., & Sun, W. (2017) · Chinese Medical Journal · doi:10.4103/0366-6999.202737 · Cited by 60
HJV gene mutations in European patients with juvenile hemochromatosis
Gehrke, S. G., Pietrangelo, A., Kascak, M., Braner, A., Eisold, M., Kulaksiz, H., Herrmann, T. R. W., Hebling, U., Bents, K., Gugler, R., et al. (2005) · Clinical Genetics · doi:10.1111/j.1399-0004.2005.00413.x · Cited by 61
Self-citationHemochromatosis (HFE) gene mutations and peripheral neuropathy during antiretroviral therapy
Kallianpur, A. R., Hulgan, T., Canter, J. A., Ritchie, M. D., Haines, J. L., Robbins, G. K., Shafer, R. W., Clifford, D. B., & Haas, D. W. (2006) · AIDS · doi:10.1097/01.aids.0000237366.56864.3c · Cited by 61
Iron excess in recreational marathon runners
Mettler, S., & Zimmermann, M. B. (2010) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2010.16 · Cited by 60
Koyama, C., Wakusawa, S., Hayashi, H., Suzuki, R., Yano, M., Yoshioka, K., Kozuru, M., Takayamam, Y., Okada, T., & Mabuchi, H. (2005) · PubMed · Cited by 59
Fatih, N., Camberlein, E., Island, M. L., Corlu, A., Abgueguen, E., Détivaud, L., Leroyer, P., Brissot, P., & Loréal, O. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0588-3 · Cited by 59
Metadata
- Authors
- Pietrangelo, A.
- Affiliations
- University of Modena and Reggio Emilia (IT)
- Corresponding author
- Pietrangelo, Antonello
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-06-03
- Volume
- 350
- Issue
- 23
- Pages
- 2383-2397
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2168051647
- Cited by
- 992
- References
- 97
- Citations by year
- 2026: 12 · 2025: 11 · 2024: 16 · 2023: 17 · 2022: 22 · 2021: 18 · 2020: 21 · 2019: 21 · 2018: 38 · 2017: 38 · 2016: 37 · 2015: 42 · 2014: 34 · 2013: 42 · 2012: 41
- FWCI
- 11.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- hereditary hemochromatosis, HFE gene, iron overload, iron metabolism genes, disease management, diabetes mellitus, liver cirrhosis
- MeSH terms
- Hemochromatosis Protein, Genotype, Hemochromatosis, Homeostasis, Humans, Iron, Membrane Proteins, Mutation, Phenotype, Receptors, Transferrin, Histocompatibility Antigens Class I, Iron Overload, Antimicrobial Cationic Peptides, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
